ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 198 filers reported holding ROYALTY PHARMA PLC in Q4 2020. The put-call ratio across all filers is 2.07 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,766,311 | +73.1% | 1,133,615 | +96.1% | 0.10% | +72.7% |
| Q2 2023 | $17,769,350 | +61.4% | 578,053 | +89.2% | 0.06% | +41.0% |
| Q1 2023 | $11,007,454 | -13.4% | 305,508 | -5.0% | 0.04% | -15.2% |
| Q4 2022 | $12,707,972 | +4.4% | 321,558 | +6.1% | 0.05% | -19.3% |
| Q3 2022 | $12,178,000 | -20.9% | 303,093 | -17.2% | 0.06% | -12.3% |
| Q2 2022 | $15,395,000 | +124.4% | 366,203 | +107.9% | 0.06% | +170.8% |
| Q1 2022 | $6,861,000 | +321.4% | 176,115 | +331.1% | 0.02% | +380.0% |
| Q4 2021 | $1,628,000 | +54.0% | 40,856 | +68.6% | 0.01% | 0.0% |
| Q1 2021 | $1,057,000 | -32.2% | 24,232 | -34.6% | 0.01% | -16.7% |
| Q3 2020 | $1,559,000 | – | 37,062 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |